Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma patients: a prospective non-randomized controlled study

OBJECTIVE: Anti-angiogenic drugs are an emerging treatment option against malignant tumors. The aim of this study was to determine whether the addition of perioperative rh-endostatin to chemotherapy could improve the probability of distant metastasis-free survival (DMFS) and overall survival (OS) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hairong, Huang, Zhen, Li, Yuan, Zhang, Qing, Hao, Lin, Niu, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528451/
https://www.ncbi.nlm.nih.gov/pubmed/31119057
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528451/
https://www.ncbi.nlm.nih.gov/pubmed/31119057
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0315

Ejemplares similares